Major adverse kidney events predict reduced survival in ventricular assist device supported patients.
Sumita BaruaSean M ConteCallum CherrettKatherine L KearneyDesiree RobsonChristopher BraggPeter S MacdonaldKavitha MuthiahChristopher S HaywardPublished in: ESC heart failure (2023)
MAKE significantly impacts survival. In our cohort, MAKE was predicted by post-implant right ventricular failure and chronic haemolysis. The lack of early eGFR improvement on VAD support may indicate higher risk for MAKE.